

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.14818818 |
| 2 | negative T cell selection (GO:0043383) | 5.92359461 |
| 3 | negative thymic T cell selection (GO:0045060) | 5.85307885 |
| 4 | negative regulation of cell killing (GO:0031342) | 5.54716303 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.54716303 |
| 6 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.49606990 |
| 7 | positive thymic T cell selection (GO:0045059) | 5.47388614 |
| 8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.41677916 |
| 9 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.41286344 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.41286344 |
| 11 | leukocyte aggregation (GO:0070486) | 5.26576051 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.23786971 |
| 13 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.23290087 |
| 14 | tolerance induction (GO:0002507) | 5.13717056 |
| 15 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.10523138 |
| 16 | cellular response to interleukin-15 (GO:0071350) | 5.00924268 |
| 17 | response to interleukin-15 (GO:0070672) | 4.99895646 |
| 18 | thymic T cell selection (GO:0045061) | 4.94346109 |
| 19 | interferon-gamma production (GO:0032609) | 4.92956457 |
| 20 | positive T cell selection (GO:0043368) | 4.76063710 |
| 21 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.68765003 |
| 22 | regulation of gamma-delta T cell activation (GO:0046643) | 4.68457729 |
| 23 | T cell selection (GO:0045058) | 4.63391761 |
| 24 | regulation of T cell tolerance induction (GO:0002664) | 4.44711038 |
| 25 | T cell migration (GO:0072678) | 4.41389993 |
| 26 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.37626618 |
| 27 | regulation of B cell differentiation (GO:0045577) | 4.35809679 |
| 28 | negative regulation of T cell mediated immunity (GO:0002710) | 4.25898748 |
| 29 | B cell receptor signaling pathway (GO:0050853) | 4.21315330 |
| 30 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.20571288 |
| 31 | cytidine metabolic process (GO:0046087) | 4.09163995 |
| 32 | cytidine catabolic process (GO:0006216) | 4.09163995 |
| 33 | cytidine deamination (GO:0009972) | 4.09163995 |
| 34 | T cell costimulation (GO:0031295) | 3.99030436 |
| 35 | lymphocyte costimulation (GO:0031294) | 3.97737797 |
| 36 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.97408056 |
| 37 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.95346903 |
| 38 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.92915711 |
| 39 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.86458649 |
| 40 | T cell receptor signaling pathway (GO:0050852) | 3.84410475 |
| 41 | positive regulation of B cell differentiation (GO:0045579) | 3.84177516 |
| 42 | negative regulation of B cell proliferation (GO:0030889) | 3.77689033 |
| 43 | NIK/NF-kappaB signaling (GO:0038061) | 3.72955525 |
| 44 | positive regulation of interleukin-2 production (GO:0032743) | 3.72412173 |
| 45 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.64454106 |
| 46 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.63878967 |
| 47 | positive regulation of isotype switching (GO:0045830) | 3.60728204 |
| 48 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.58213066 |
| 49 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.54879886 |
| 50 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.54751833 |
| 51 | positive regulation of granulocyte differentiation (GO:0030854) | 3.50624648 |
| 52 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.48603610 |
| 53 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.45209234 |
| 54 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.44775029 |
| 55 | regulation of regulatory T cell differentiation (GO:0045589) | 3.44692395 |
| 56 | mature B cell differentiation (GO:0002335) | 3.42621336 |
| 57 | positive regulation of tolerance induction (GO:0002645) | 3.42071685 |
| 58 | regulation of tolerance induction (GO:0002643) | 3.41222362 |
| 59 | dendritic cell migration (GO:0036336) | 3.40349203 |
| 60 | dendritic cell chemotaxis (GO:0002407) | 3.39083100 |
| 61 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.38903486 |
| 62 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.38903486 |
| 63 | DNA deamination (GO:0045006) | 3.37477956 |
| 64 | leukocyte cell-cell adhesion (GO:0007159) | 3.35754246 |
| 65 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.35692559 |
| 66 | regulation of isotype switching (GO:0045191) | 3.34981461 |
| 67 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.34823267 |
| 68 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.33965746 |
| 69 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.32388232 |
| 70 | regulation of B cell proliferation (GO:0030888) | 3.30871064 |
| 71 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.30271087 |
| 72 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.29950893 |
| 73 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.24397879 |
| 74 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.24103032 |
| 75 | modulation by symbiont of host immune response (GO:0052553) | 3.24103032 |
| 76 | positive regulation by symbiont of host defense response (GO:0052509) | 3.24103032 |
| 77 | modulation by symbiont of host defense response (GO:0052031) | 3.24103032 |
| 78 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.24103032 |
| 79 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.24103032 |
| 80 | activated T cell proliferation (GO:0050798) | 3.20321440 |
| 81 | neutrophil activation involved in immune response (GO:0002283) | 3.19629038 |
| 82 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.19109125 |
| 83 | myeloid dendritic cell activation (GO:0001773) | 3.17030842 |
| 84 | granulocyte activation (GO:0036230) | 3.16063933 |
| 85 | regulation of chronic inflammatory response (GO:0002676) | 3.15776062 |
| 86 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.11471616 |
| 87 | regulation of cell killing (GO:0031341) | 3.10911779 |
| 88 | positive regulation of DNA recombination (GO:0045911) | 3.10345121 |
| 89 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.07705259 |
| 90 | myeloid cell activation involved in immune response (GO:0002275) | 3.07432468 |
| 91 | T-helper cell differentiation (GO:0042093) | 3.07331163 |
| 92 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.07331163 |
| 93 | B cell proliferation (GO:0042100) | 3.07288450 |
| 94 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.07042817 |
| 95 | negative regulation of adaptive immune response (GO:0002820) | 3.07008048 |
| 96 | cellular extravasation (GO:0045123) | 3.03686749 |
| 97 | regulation of B cell activation (GO:0050864) | 3.03398441 |
| 98 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.03339392 |
| 99 | positive regulation of cell killing (GO:0031343) | 3.03303632 |
| 100 | hepatocyte apoptotic process (GO:0097284) | 3.02957338 |
| 101 | negative regulation of interleukin-12 production (GO:0032695) | 3.02853517 |
| 102 | alpha-beta T cell activation (GO:0046631) | 3.02467613 |
| 103 | cellular response to zinc ion (GO:0071294) | 3.01326312 |
| 104 | leukocyte degranulation (GO:0043299) | 3.00772071 |
| 105 | mast cell activation (GO:0045576) | 3.00701266 |
| 106 | lymphocyte chemotaxis (GO:0048247) | 3.00649806 |
| 107 | T cell homeostasis (GO:0043029) | 2.98229818 |
| 108 | lymphocyte homeostasis (GO:0002260) | 2.97180816 |
| 109 | regulation of B cell mediated immunity (GO:0002712) | 2.95398696 |
| 110 | detection of other organism (GO:0098543) | 2.94830076 |
| 111 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.94027899 |
| 112 | myeloid dendritic cell differentiation (GO:0043011) | 2.93887971 |
| 113 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.93032340 |
| 114 | regulation of response to interferon-gamma (GO:0060330) | 2.92708525 |
| 115 | regulation of alpha-beta T cell activation (GO:0046634) | 2.92105869 |
| 116 | positive regulation of B cell activation (GO:0050871) | 2.91671669 |
| 117 | regulation of immunoglobulin production (GO:0002637) | 2.91500164 |
| 118 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.91201360 |
| 119 | positive regulation of B cell mediated immunity (GO:0002714) | 2.91201360 |
| 120 | positive regulation of B cell proliferation (GO:0030890) | 2.88402975 |
| 121 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.87518498 |
| 122 | immunoglobulin mediated immune response (GO:0016064) | 2.86823826 |
| 123 | alpha-beta T cell differentiation (GO:0046632) | 2.86654465 |
| 124 | macrophage activation involved in immune response (GO:0002281) | 2.86622796 |
| 125 | T cell proliferation (GO:0042098) | 2.85989592 |
| 126 | negative regulation of T cell apoptotic process (GO:0070233) | 2.84768235 |
| 127 | positive regulation of immunoglobulin production (GO:0002639) | 2.84671509 |
| 128 | lymphocyte migration (GO:0072676) | 2.84582837 |
| 129 | response to muramyl dipeptide (GO:0032495) | 2.83226284 |
| 130 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.83190004 |
| 131 | negative regulation of B cell activation (GO:0050869) | 2.81941813 |
| 132 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.81240411 |
| 133 | mature B cell differentiation involved in immune response (GO:0002313) | 2.80804648 |
| 134 | neutrophil activation (GO:0042119) | 2.80670938 |
| 135 | T cell differentiation (GO:0030217) | 2.79998067 |
| 136 | B cell homeostasis (GO:0001782) | 2.78954506 |
| 137 | natural killer cell activation (GO:0030101) | 2.78855170 |
| 138 | T cell differentiation involved in immune response (GO:0002292) | 2.78810066 |
| 139 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.78810066 |
| 140 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.78810066 |
| 141 | defense response to protozoan (GO:0042832) | 2.78774243 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.48837753 |
| 2 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.47157967 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.75029430 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.89781811 |
| 5 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.73962231 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.44287537 |
| 7 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 3.34027018 |
| 8 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.29213822 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.26936824 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.17703759 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 3.14716602 |
| 12 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.14318707 |
| 13 | * MYB_26560356_Chip-Seq_TH2_Human | 3.09112167 |
| 14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.06174879 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.05434954 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.90765585 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.77703995 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.76375426 |
| 19 | MAF_26560356_Chip-Seq_TH1_Human | 2.74982771 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.70889018 |
| 21 | MYB_26560356_Chip-Seq_TH1_Human | 2.63665215 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.55518217 |
| 23 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.43443040 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.31297046 |
| 25 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.28330665 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.25491718 |
| 27 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.25141114 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.17082070 |
| 29 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.15798639 |
| 30 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.13535695 |
| 31 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.12022359 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.03169188 |
| 33 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.02264731 |
| 34 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.95243339 |
| 35 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.91412275 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.89155140 |
| 37 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.87886698 |
| 38 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.87564879 |
| 39 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.86175322 |
| 40 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.71292993 |
| 41 | * MAF_26560356_Chip-Seq_TH2_Human | 1.66128286 |
| 42 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.59525314 |
| 43 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.58823280 |
| 44 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.53866626 |
| 45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.53338889 |
| 46 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52958493 |
| 47 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.52772490 |
| 48 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47938113 |
| 49 | SPI1_23127762_ChIP-Seq_K562_Human | 1.47686271 |
| 50 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.43934613 |
| 51 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.42007500 |
| 52 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41902328 |
| 53 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.39787884 |
| 54 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.35404295 |
| 55 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33276491 |
| 56 | * FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.31356021 |
| 57 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.27614935 |
| 58 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.25035939 |
| 59 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.23010243 |
| 60 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.22644104 |
| 61 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.22365986 |
| 62 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.22009266 |
| 63 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.21947529 |
| 64 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.20860478 |
| 65 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16606292 |
| 66 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.15125214 |
| 67 | GATA1_22025678_ChIP-Seq_K562_Human | 1.14582464 |
| 68 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14438622 |
| 69 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09408240 |
| 70 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08756300 |
| 71 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08183276 |
| 72 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.07167890 |
| 73 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.06514642 |
| 74 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.04542732 |
| 75 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.04291942 |
| 76 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.03343733 |
| 77 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.98892962 |
| 78 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98394767 |
| 79 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97504415 |
| 80 | GATA3_26560356_Chip-Seq_TH1_Human | 0.96916208 |
| 81 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95479074 |
| 82 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.94353519 |
| 83 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.93544138 |
| 84 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.93045034 |
| 85 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92204133 |
| 86 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90532498 |
| 87 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.89231154 |
| 88 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.88515864 |
| 89 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.87711200 |
| 90 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.86549163 |
| 91 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86542494 |
| 92 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85746582 |
| 93 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85660287 |
| 94 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.84108994 |
| 95 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82594221 |
| 96 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.82568647 |
| 97 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.82007258 |
| 98 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.81268440 |
| 99 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.80449175 |
| 100 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.79894764 |
| 101 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78404565 |
| 102 | * PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.78374277 |
| 103 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.77347580 |
| 104 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.77233934 |
| 105 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.77037282 |
| 106 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.77008533 |
| 107 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.76599348 |
| 108 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.76023858 |
| 109 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.75929770 |
| 110 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75747698 |
| 111 | VDR_22108803_ChIP-Seq_LS180_Human | 0.75215355 |
| 112 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.74024363 |
| 113 | GATA1_19941826_ChIP-Seq_K562_Human | 0.73984247 |
| 114 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70022780 |
| 115 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69216120 |
| 116 | * RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.68143984 |
| 117 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.67384682 |
| 118 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.66899681 |
| 119 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.66877368 |
| 120 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.66008119 |
| 121 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.65507292 |
| 122 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.65098431 |
| 123 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.64537982 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.07889377 |
| 2 | MP0003763_abnormal_thymus_physiology | 3.91823222 |
| 3 | MP0005671_abnormal_response_to | 3.91420880 |
| 4 | MP0000685_abnormal_immune_system | 3.42655750 |
| 5 | MP0001800_abnormal_humoral_immune | 3.41950402 |
| 6 | MP0001790_abnormal_immune_system | 3.33027312 |
| 7 | MP0005387_immune_system_phenotype | 3.33027312 |
| 8 | * MP0005000_abnormal_immune_tolerance | 2.98111975 |
| 9 | MP0002452_abnormal_antigen_presenting | 2.87291959 |
| 10 | MP0003436_decreased_susceptibility_to | 2.79862501 |
| 11 | MP0003303_peritoneal_inflammation | 2.79651118 |
| 12 | * MP0002723_abnormal_immune_serum | 2.77249029 |
| 13 | * MP0002420_abnormal_adaptive_immunity | 2.73628941 |
| 14 | MP0001873_stomach_inflammation | 2.72740754 |
| 15 | MP0002166_altered_tumor_susceptibility | 2.72150989 |
| 16 | * MP0001819_abnormal_immune_cell | 2.70794341 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.63981544 |
| 18 | MP0009785_altered_susceptibility_to | 2.60307815 |
| 19 | * MP0002398_abnormal_bone_marrow | 2.51803680 |
| 20 | MP0001853_heart_inflammation | 2.46842858 |
| 21 | MP0005025_abnormal_response_to | 2.43130467 |
| 22 | MP0002405_respiratory_system_inflammati | 2.36459672 |
| 23 | * MP0000716_abnormal_immune_system | 2.29333846 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 2.29015848 |
| 25 | MP0002006_tumorigenesis | 2.20040324 |
| 26 | MP0002419_abnormal_innate_immunity | 2.19096483 |
| 27 | MP0004947_skin_inflammation | 2.14916902 |
| 28 | MP0009333_abnormal_splenocyte_physiolog | 2.10951999 |
| 29 | MP0000689_abnormal_spleen_morphology | 2.07309892 |
| 30 | MP0002396_abnormal_hematopoietic_system | 2.05330852 |
| 31 | MP0002722_abnormal_immune_system | 2.04016633 |
| 32 | MP0010155_abnormal_intestine_physiology | 2.02324061 |
| 33 | MP0004510_myositis | 1.99516864 |
| 34 | MP0000703_abnormal_thymus_morphology | 1.97745838 |
| 35 | MP0006082_CNS_inflammation | 1.96095297 |
| 36 | MP0003724_increased_susceptibility_to | 1.95437556 |
| 37 | * MP0002429_abnormal_blood_cell | 1.86294653 |
| 38 | MP0002933_joint_inflammation | 1.79172803 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.73500721 |
| 40 | MP0005464_abnormal_platelet_physiology | 1.69368536 |
| 41 | MP0003866_abnormal_defecation | 1.67347533 |
| 42 | MP0002009_preneoplasia | 1.66435496 |
| 43 | MP0004808_abnormal_hematopoietic_stem | 1.61812839 |
| 44 | MP0005310_abnormal_salivary_gland | 1.60587978 |
| 45 | MP0000465_gastrointestinal_hemorrhage | 1.57974729 |
| 46 | MP0010352_gastrointestinal_tract_polyps | 1.55723717 |
| 47 | MP0001533_abnormal_skeleton_physiology | 1.42248716 |
| 48 | MP0000858_altered_metastatic_potential | 1.39274840 |
| 49 | MP0003448_altered_tumor_morphology | 1.34686238 |
| 50 | MP0008057_abnormal_DNA_replication | 1.33001455 |
| 51 | MP0005397_hematopoietic_system_phenotyp | 1.29365803 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.29365803 |
| 53 | MP0002138_abnormal_hepatobiliary_system | 1.26514630 |
| 54 | MP0000490_abnormal_crypts_of | 1.26188334 |
| 55 | MP0009278_abnormal_bone_marrow | 1.23534084 |
| 56 | MP0008469_abnormal_protein_level | 1.11376605 |
| 57 | MP0000015_abnormal_ear_pigmentation | 1.07312214 |
| 58 | MP0003172_abnormal_lysosome_physiology | 1.06899084 |
| 59 | MP0002998_abnormal_bone_remodeling | 1.01536380 |
| 60 | MP0005076_abnormal_cell_differentiation | 1.00088983 |
| 61 | MP0001851_eye_inflammation | 0.99458626 |
| 62 | MP0002019_abnormal_tumor_incidence | 0.94425087 |
| 63 | MP0005023_abnormal_wound_healing | 0.93322743 |
| 64 | MP0004883_abnormal_blood_vessel | 0.91739359 |
| 65 | MP0003453_abnormal_keratinocyte_physiol | 0.91510042 |
| 66 | MP0003656_abnormal_erythrocyte_physiolo | 0.89485089 |
| 67 | MP0009764_decreased_sensitivity_to | 0.86680637 |
| 68 | MP0000343_altered_response_to | 0.83019444 |
| 69 | MP0003045_fibrosis | 0.82617097 |
| 70 | MP0005174_abnormal_tail_pigmentation | 0.81693227 |
| 71 | MP0008260_abnormal_autophagy | 0.79023812 |
| 72 | MP0003828_pulmonary_edema | 0.78536756 |
| 73 | MP0003252_abnormal_bile_duct | 0.76153419 |
| 74 | MP0003183_abnormal_peptide_metabolism | 0.76103233 |
| 75 | MP0002277_abnormal_respiratory_mucosa | 0.75808603 |
| 76 | MP0001919_abnormal_reproductive_system | 0.73371229 |
| 77 | MP0001663_abnormal_digestive_system | 0.72723233 |
| 78 | MP0002163_abnormal_gland_morphology | 0.70401041 |
| 79 | MP0003795_abnormal_bone_structure | 0.69487683 |
| 80 | MP0002132_abnormal_respiratory_system | 0.69470201 |
| 81 | MP0003091_abnormal_cell_migration | 0.67444907 |
| 82 | MP0001243_abnormal_dermal_layer | 0.67404629 |
| 83 | MP0009763_increased_sensitivity_to | 0.66333741 |
| 84 | MP0008007_abnormal_cellular_replicative | 0.66195311 |
| 85 | MP0003566_abnormal_cell_adhesion | 0.65874539 |
| 86 | MP0005164_abnormal_response_to | 0.65647255 |
| 87 | MP0003077_abnormal_cell_cycle | 0.65417182 |
| 88 | MP0000249_abnormal_blood_vessel | 0.65047204 |
| 89 | MP0005075_abnormal_melanosome_morpholog | 0.64626406 |
| 90 | MP0010307_abnormal_tumor_latency | 0.64580987 |
| 91 | MP0001348_abnormal_lacrimal_gland | 0.64507382 |
| 92 | MP0005390_skeleton_phenotype | 0.64489855 |
| 93 | MP0003075_altered_response_to | 0.62912961 |
| 94 | MP0001216_abnormal_epidermal_layer | 0.60935218 |
| 95 | MP0008877_abnormal_DNA_methylation | 0.60527647 |
| 96 | MP0004381_abnormal_hair_follicle | 0.60440562 |
| 97 | MP0002876_abnormal_thyroid_physiology | 0.60292558 |
| 98 | MP0001191_abnormal_skin_condition | 0.59855801 |
| 99 | MP0002136_abnormal_kidney_physiology | 0.59038660 |
| 100 | MP0005451_abnormal_body_composition | 0.59001829 |
| 101 | MP0006054_spinal_hemorrhage | 0.58970769 |
| 102 | MP0010234_abnormal_vibrissa_follicle | 0.58598528 |
| 103 | MP0003279_aneurysm | 0.57043759 |
| 104 | MP0000477_abnormal_intestine_morphology | 0.57011528 |
| 105 | MP0005166_decreased_susceptibility_to | 0.56641544 |
| 106 | MP0002877_abnormal_melanocyte_morpholog | 0.55413796 |
| 107 | MP0003786_premature_aging | 0.54790249 |
| 108 | MP0000569_abnormal_digit_pigmentation | 0.53619021 |
| 109 | MP0004484_altered_response_of | 0.53198854 |
| 110 | MP0001765_abnormal_ion_homeostasis | 0.52652534 |
| 111 | MP0004130_abnormal_muscle_cell | 0.52007555 |
| 112 | MP0005058_abnormal_lysosome_morphology | 0.48778225 |
| 113 | MP0008873_increased_physiological_sensi | 0.48417697 |
| 114 | MP0001986_abnormal_taste_sensitivity | 0.48235476 |
| 115 | MP0001501_abnormal_sleep_pattern | 0.47345762 |
| 116 | MP0003191_abnormal_cellular_cholesterol | 0.46914886 |
| 117 | MP0002693_abnormal_pancreas_physiology | 0.46894819 |
| 118 | MP0000367_abnormal_coat/_hair | 0.45387815 |
| 119 | MP0002254_reproductive_system_inflammat | 0.45353767 |
| 120 | MP0000609_abnormal_liver_physiology | 0.44730310 |
| 121 | MP0000372_irregular_coat_pigmentation | 0.44615155 |
| 122 | MP0009765_abnormal_xenobiotic_induced | 0.44587768 |
| 123 | MP0000604_amyloidosis | 0.44468139 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myositis (HP:0100614) | 4.99182384 |
| 2 | T lymphocytopenia (HP:0005403) | 4.89427460 |
| 3 | Abnormality of T cell number (HP:0011839) | 4.79412282 |
| 4 | IgM deficiency (HP:0002850) | 4.64488072 |
| 5 | Optic neuritis (HP:0100653) | 4.59408794 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 4.59408794 |
| 7 | Eczematoid dermatitis (HP:0000976) | 4.54018835 |
| 8 | Stomatitis (HP:0010280) | 4.50831958 |
| 9 | Recurrent bronchitis (HP:0002837) | 4.48979392 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.31238216 |
| 11 | Orchitis (HP:0100796) | 4.29576811 |
| 12 | Recurrent fungal infections (HP:0002841) | 4.17570869 |
| 13 | Recurrent abscess formation (HP:0002722) | 4.11864870 |
| 14 | Recurrent viral infections (HP:0004429) | 4.08696353 |
| 15 | Abnormality of T cells (HP:0002843) | 4.07579410 |
| 16 | Agammaglobulinemia (HP:0004432) | 3.94417291 |
| 17 | Vasculitis (HP:0002633) | 3.85254336 |
| 18 | Meningitis (HP:0001287) | 3.79919889 |
| 19 | Chronic otitis media (HP:0000389) | 3.73604835 |
| 20 | IgG deficiency (HP:0004315) | 3.71171655 |
| 21 | Panhypogammaglobulinemia (HP:0003139) | 3.69206155 |
| 22 | Recurrent bacterial skin infections (HP:0005406) | 3.63000154 |
| 23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.59909159 |
| 24 | Severe combined immunodeficiency (HP:0004430) | 3.55224423 |
| 25 | Pulmonary infiltrates (HP:0002113) | 3.53616896 |
| 26 | Chronic obstructive pulmonary disease (HP:0006510) | 3.49819892 |
| 27 | Obstructive lung disease (HP:0006536) | 3.49819892 |
| 28 | Mediastinal lymphadenopathy (HP:0100721) | 3.47176333 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.41059891 |
| 30 | Recurrent cutaneous fungal infections (HP:0011370) | 3.41059891 |
| 31 | Combined immunodeficiency (HP:0005387) | 3.39826617 |
| 32 | Lymphopenia (HP:0001888) | 3.38192809 |
| 33 | Abnormality of B cell number (HP:0010975) | 3.36333699 |
| 34 | B lymphocytopenia (HP:0010976) | 3.36333699 |
| 35 | Thyroiditis (HP:0100646) | 3.30436918 |
| 36 | Abnormality of T cell physiology (HP:0011840) | 3.30069792 |
| 37 | Inflammation of the large intestine (HP:0002037) | 3.28971085 |
| 38 | Recurrent sinusitis (HP:0011108) | 3.26979408 |
| 39 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.26908837 |
| 40 | Arterial thrombosis (HP:0004420) | 3.22964928 |
| 41 | Nasal polyposis (HP:0100582) | 3.22340371 |
| 42 | Gastrointestinal stroma tumor (HP:0100723) | 3.20631587 |
| 43 | Keratoconjunctivitis sicca (HP:0001097) | 3.18829553 |
| 44 | Hemoptysis (HP:0002105) | 3.18273886 |
| 45 | Spontaneous hematomas (HP:0007420) | 3.17074489 |
| 46 | IgA deficiency (HP:0002720) | 3.14097331 |
| 47 | Gastrointestinal inflammation (HP:0004386) | 3.13500353 |
| 48 | Encephalitis (HP:0002383) | 3.10390222 |
| 49 | Pustule (HP:0200039) | 3.08757288 |
| 50 | Autoimmune thrombocytopenia (HP:0001973) | 3.04730520 |
| 51 | Chronic diarrhea (HP:0002028) | 3.02054585 |
| 52 | Abnormality of the fingertips (HP:0001211) | 3.01361040 |
| 53 | Colitis (HP:0002583) | 2.99828755 |
| 54 | Cellulitis (HP:0100658) | 2.98572028 |
| 55 | Recurrent skin infections (HP:0001581) | 2.95415342 |
| 56 | Abnormality of the prostate (HP:0008775) | 2.94495178 |
| 57 | Keratoconjunctivitis (HP:0001096) | 2.87632697 |
| 58 | Abnormality of eosinophils (HP:0001879) | 2.84215250 |
| 59 | Abnormality of the nasal mucosa (HP:0000433) | 2.83987921 |
| 60 | Increased IgE level (HP:0003212) | 2.82392020 |
| 61 | Chest pain (HP:0100749) | 2.78837839 |
| 62 | Leukocytosis (HP:0001974) | 2.75670075 |
| 63 | Gastrointestinal infarctions (HP:0005244) | 2.71304360 |
| 64 | Eosinophilia (HP:0001880) | 2.70705815 |
| 65 | Papilloma (HP:0012740) | 2.70397756 |
| 66 | Verrucae (HP:0200043) | 2.70397756 |
| 67 | Autoimmune hemolytic anemia (HP:0001890) | 2.69218721 |
| 68 | Thrombocytosis (HP:0001894) | 2.64468887 |
| 69 | Stomach cancer (HP:0012126) | 2.63927492 |
| 70 | Pulmonary embolism (HP:0002204) | 2.63312038 |
| 71 | Increased IgM level (HP:0003496) | 2.61701803 |
| 72 | Anorexia (HP:0002039) | 2.61668492 |
| 73 | Lymphoma (HP:0002665) | 2.59047634 |
| 74 | Bronchitis (HP:0012387) | 2.53390063 |
| 75 | Emphysema (HP:0002097) | 2.51781228 |
| 76 | Hypoplasia of the thymus (HP:0000778) | 2.47275373 |
| 77 | Urticaria (HP:0001025) | 2.40935542 |
| 78 | Gangrene (HP:0100758) | 2.40606210 |
| 79 | Granulocytopenia (HP:0001913) | 2.36187335 |
| 80 | Alveolar cell carcinoma (HP:0006519) | 2.34425041 |
| 81 | Gingivitis (HP:0000230) | 2.33612345 |
| 82 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.30186697 |
| 83 | Hematochezia (HP:0002573) | 2.27670245 |
| 84 | Restrictive lung disease (HP:0002091) | 2.26413623 |
| 85 | Epistaxis (HP:0000421) | 2.26357580 |
| 86 | Pulmonary fibrosis (HP:0002206) | 2.25469083 |
| 87 | Hypergammaglobulinemia (HP:0010702) | 2.23529592 |
| 88 | Keratitis (HP:0000491) | 2.23357006 |
| 89 | Abnormality of macrophages (HP:0004311) | 2.20689333 |
| 90 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.18646817 |
| 91 | Hypoproteinemia (HP:0003075) | 2.18213935 |
| 92 | Osteomyelitis (HP:0002754) | 2.17856868 |
| 93 | Chronic sinusitis (HP:0011109) | 2.17742903 |
| 94 | Ureteral stenosis (HP:0000071) | 2.16648523 |
| 95 | Fatigue (HP:0012378) | 2.15191016 |
| 96 | Glomerulopathy (HP:0100820) | 2.14225973 |
| 97 | Periodontitis (HP:0000704) | 2.13798861 |
| 98 | Polyneuropathy (HP:0001271) | 2.12658998 |
| 99 | Petechiae (HP:0000967) | 2.12562310 |
| 100 | Amaurosis fugax (HP:0100576) | 2.11568348 |
| 101 | Prolonged bleeding time (HP:0003010) | 2.11209279 |
| 102 | Hypochromic anemia (HP:0001931) | 2.11020565 |
| 103 | Joint swelling (HP:0001386) | 2.10801679 |
| 104 | Skin rash (HP:0000988) | 2.10591487 |
| 105 | Skin ulcer (HP:0200042) | 2.08152097 |
| 106 | Gingival bleeding (HP:0000225) | 2.07935069 |
| 107 | Increased density of long bones (HP:0006392) | 2.07254495 |
| 108 | Ureteral obstruction (HP:0006000) | 2.05485323 |
| 109 | Abnormality of the pleura (HP:0002103) | 2.03657385 |
| 110 | Recurrent pneumonia (HP:0006532) | 2.03235655 |
| 111 | Papilledema (HP:0001085) | 2.02250717 |
| 112 | Interstitial pulmonary disease (HP:0006530) | 2.02040279 |
| 113 | Abnormal platelet volume (HP:0011876) | 2.00645368 |
| 114 | Thrombophlebitis (HP:0004418) | 1.96598272 |
| 115 | Vertigo (HP:0002321) | 1.91057813 |
| 116 | Acute hepatic failure (HP:0006554) | 1.90720863 |
| 117 | Arthralgia (HP:0002829) | 1.90362938 |
| 118 | Abnormality of the pericardium (HP:0001697) | 1.88577480 |
| 119 | Prostate neoplasm (HP:0100787) | 1.86373624 |
| 120 | Abnormality of the endocardium (HP:0004306) | 1.85224688 |
| 121 | Episodic fever (HP:0001954) | 1.82803975 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.08675595 |
| 2 | MAP4K1 | 5.35624349 |
| 3 | STK10 | 2.90902420 |
| 4 | ITK | 2.87722093 |
| 5 | JAK3 | 2.67287561 |
| 6 | MAP3K14 | 2.59606030 |
| 7 | TYK2 | 2.48135711 |
| 8 | ZAP70 | 2.43923822 |
| 9 | GRK6 | 2.24885503 |
| 10 | IKBKE | 2.16671017 |
| 11 | TEC | 2.12984901 |
| 12 | JAK1 | 2.09981046 |
| 13 | BTK | 1.98655785 |
| 14 | BLK | 1.98335377 |
| 15 | MST4 | 1.86171719 |
| 16 | BMPR2 | 1.83843600 |
| 17 | TBK1 | 1.81437251 |
| 18 | FGFR4 | 1.80659956 |
| 19 | IRAK4 | 1.78129632 |
| 20 | IKBKB | 1.77144032 |
| 21 | MAP3K10 | 1.74884102 |
| 22 | MAP3K13 | 1.74743963 |
| 23 | FGFR3 | 1.70898487 |
| 24 | LCK | 1.66719112 |
| 25 | SYK | 1.63332617 |
| 26 | CSK | 1.62952852 |
| 27 | LRRK2 | 1.54192412 |
| 28 | CAMKK2 | 1.51779864 |
| 29 | TGFBR2 | 1.49468051 |
| 30 | HCK | 1.47489844 |
| 31 | NLK | 1.43599119 |
| 32 | KIT | 1.40997928 |
| 33 | PIM1 | 1.32974545 |
| 34 | CSF1R | 1.29905192 |
| 35 | IRAK3 | 1.27103973 |
| 36 | CHUK | 1.25261811 |
| 37 | RPS6KA4 | 1.22927058 |
| 38 | FRK | 1.20111017 |
| 39 | MARK3 | 1.16575219 |
| 40 | EPHB1 | 1.14795341 |
| 41 | EEF2K | 1.13496128 |
| 42 | PRKCQ | 1.02052377 |
| 43 | CDK12 | 1.01914087 |
| 44 | ERN1 | 0.98331598 |
| 45 | LYN | 0.98140405 |
| 46 | MAP2K3 | 0.94390729 |
| 47 | RIPK4 | 0.93884886 |
| 48 | PRPF4B | 0.92081508 |
| 49 | JAK2 | 0.90001508 |
| 50 | EPHA3 | 0.87404359 |
| 51 | GRK7 | 0.84735865 |
| 52 | TESK2 | 0.82743563 |
| 53 | MAP2K2 | 0.81805037 |
| 54 | CLK1 | 0.81764650 |
| 55 | ACVR1B | 0.76030795 |
| 56 | KDR | 0.73784414 |
| 57 | FGR | 0.73514527 |
| 58 | FES | 0.72112232 |
| 59 | SIK3 | 0.71392235 |
| 60 | MATK | 0.70848436 |
| 61 | FLT3 | 0.66820568 |
| 62 | TAOK3 | 0.65132195 |
| 63 | CDK9 | 0.64945457 |
| 64 | IRAK2 | 0.62664332 |
| 65 | SIK2 | 0.60199972 |
| 66 | CDK6 | 0.60086931 |
| 67 | PIK3CA | 0.59791992 |
| 68 | MAP3K1 | 0.59354497 |
| 69 | ERBB3 | 0.59079617 |
| 70 | CDK4 | 0.58461230 |
| 71 | CAMKK1 | 0.57105656 |
| 72 | MELK | 0.57032685 |
| 73 | PRKCH | 0.55262229 |
| 74 | STK4 | 0.54676117 |
| 75 | TNK2 | 0.53699216 |
| 76 | GRK5 | 0.51621953 |
| 77 | NEK9 | 0.49718729 |
| 78 | PDK1 | 0.49473267 |
| 79 | TLK1 | 0.49027235 |
| 80 | STK24 | 0.48846683 |
| 81 | NEK6 | 0.46974595 |
| 82 | TRPM7 | 0.44331004 |
| 83 | IRAK1 | 0.44075318 |
| 84 | ADRBK2 | 0.43802082 |
| 85 | PDGFRB | 0.43618278 |
| 86 | MAP3K2 | 0.43191952 |
| 87 | HIPK2 | 0.43006211 |
| 88 | NME2 | 0.42449600 |
| 89 | EIF2AK3 | 0.42325091 |
| 90 | TTN | 0.42043852 |
| 91 | RPS6KA5 | 0.41185260 |
| 92 | MAPKAPK2 | 0.40626852 |
| 93 | PTK6 | 0.40577780 |
| 94 | NEK2 | 0.40511778 |
| 95 | MAP3K12 | 0.40467793 |
| 96 | SGK2 | 0.40356371 |
| 97 | PKN2 | 0.38039320 |
| 98 | FYN | 0.36508800 |
| 99 | MAP3K8 | 0.36388576 |
| 100 | INSR | 0.35724557 |
| 101 | BRD4 | 0.34815968 |
| 102 | PTK2B | 0.34807766 |
| 103 | NUAK1 | 0.34200812 |
| 104 | MAP3K7 | 0.34156963 |
| 105 | ABL1 | 0.33168082 |
| 106 | MAPK7 | 0.33076365 |
| 107 | SGK3 | 0.32008185 |
| 108 | MAPK11 | 0.31633046 |
| 109 | IGF1R | 0.31270350 |
| 110 | ALK | 0.31202134 |
| 111 | MAP2K6 | 0.30924946 |
| 112 | MAPK12 | 0.30904735 |
| 113 | MAP3K11 | 0.30457826 |
| 114 | DMPK | 0.30076240 |
| 115 | PIK3CG | 0.29725519 |
| 116 | MAPKAPK3 | 0.29043238 |
| 117 | YES1 | 0.28973528 |
| 118 | MAPK3 | 0.26885113 |
| 119 | TRIB3 | 0.25967330 |
| 120 | MAPK4 | 0.24749993 |
| 121 | EGFR | 0.23669874 |
| 122 | PIM2 | 0.23599111 |
| 123 | PRKCD | 0.23230772 |
| 124 | PRKD2 | 0.22618050 |
| 125 | MAP3K3 | 0.22255189 |
| 126 | RPS6KB2 | 0.21782225 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.42016571 |
| 2 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.18216424 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.99898056 |
| 4 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.94677173 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.84312882 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.65560969 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.61032814 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.51986528 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.50733679 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.40275951 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.35553824 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.34326677 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.31874229 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.26762893 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.12609529 |
| 16 | Asthma_Homo sapiens_hsa05310 | 1.92723797 |
| 17 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.68958531 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.61157561 |
| 19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.60279322 |
| 20 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.60215136 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.53537420 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.53110158 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.52159955 |
| 24 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.47813279 |
| 25 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.45541056 |
| 26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.41196918 |
| 27 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.38234498 |
| 28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.33819819 |
| 29 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.32959970 |
| 30 | Hepatitis B_Homo sapiens_hsa05161 | 1.32826248 |
| 31 | Shigellosis_Homo sapiens_hsa05131 | 1.31720677 |
| 32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.25469949 |
| 33 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.25330451 |
| 34 | Apoptosis_Homo sapiens_hsa04210 | 1.25028899 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.24889201 |
| 36 | Influenza A_Homo sapiens_hsa05164 | 1.24453194 |
| 37 | Malaria_Homo sapiens_hsa05144 | 1.22253616 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.17487131 |
| 39 | Tuberculosis_Homo sapiens_hsa05152 | 1.16184597 |
| 40 | Legionellosis_Homo sapiens_hsa05134 | 1.11258035 |
| 41 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.07694618 |
| 42 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.06114058 |
| 43 | Platelet activation_Homo sapiens_hsa04611 | 1.02820975 |
| 44 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.02786328 |
| 45 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.99507878 |
| 46 | Pertussis_Homo sapiens_hsa05133 | 0.97944917 |
| 47 | HTLV-I infection_Homo sapiens_hsa05166 | 0.95094114 |
| 48 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.93550440 |
| 49 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.88793289 |
| 50 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.87468660 |
| 51 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.82162508 |
| 52 | Salmonella infection_Homo sapiens_hsa05132 | 0.81621534 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 0.80154860 |
| 54 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.76534481 |
| 55 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.76406166 |
| 56 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.75001397 |
| 57 | Colorectal cancer_Homo sapiens_hsa05210 | 0.73441922 |
| 58 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.72539951 |
| 59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.71261278 |
| 60 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.71167233 |
| 61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70581230 |
| 62 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.68643136 |
| 63 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.63815249 |
| 64 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.63712204 |
| 65 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.61961740 |
| 66 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.61634436 |
| 67 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59858089 |
| 68 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.59343915 |
| 69 | Ribosome_Homo sapiens_hsa03010 | 0.55299919 |
| 70 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.55122411 |
| 71 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.53040645 |
| 72 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.52062390 |
| 73 | Phagosome_Homo sapiens_hsa04145 | 0.51876758 |
| 74 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51145268 |
| 75 | Endocytosis_Homo sapiens_hsa04144 | 0.49545513 |
| 76 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49247681 |
| 77 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.48699485 |
| 78 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.48058306 |
| 79 | Base excision repair_Homo sapiens_hsa03410 | 0.47919491 |
| 80 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44021882 |
| 81 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.40191395 |
| 82 | Prostate cancer_Homo sapiens_hsa05215 | 0.40139901 |
| 83 | Spliceosome_Homo sapiens_hsa03040 | 0.40122023 |
| 84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39193437 |
| 85 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.38628093 |
| 86 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.38157749 |
| 87 | Insulin resistance_Homo sapiens_hsa04931 | 0.37836750 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.37782969 |
| 89 | Other glycan degradation_Homo sapiens_hsa00511 | 0.37761173 |
| 90 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.37319263 |
| 91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.36789635 |
| 92 | DNA replication_Homo sapiens_hsa03030 | 0.33973667 |
| 93 | Pathways in cancer_Homo sapiens_hsa05200 | 0.33500836 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.33148028 |
| 95 | Adherens junction_Homo sapiens_hsa04520 | 0.32476236 |
| 96 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.31817195 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.31792131 |
| 98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.31487924 |
| 99 | Mismatch repair_Homo sapiens_hsa03430 | 0.31024669 |
| 100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.29300674 |
| 101 | RNA degradation_Homo sapiens_hsa03018 | 0.27142066 |
| 102 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.26976821 |
| 103 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.26697289 |
| 104 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.26256044 |
| 105 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.26106325 |
| 106 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.25811880 |
| 107 | Circadian rhythm_Homo sapiens_hsa04710 | 0.24718886 |
| 108 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.23919496 |
| 109 | Focal adhesion_Homo sapiens_hsa04510 | 0.23457756 |
| 110 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.22354542 |
| 111 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.22215942 |
| 112 | Amoebiasis_Homo sapiens_hsa05146 | 0.21851202 |
| 113 | Cell cycle_Homo sapiens_hsa04110 | 0.21507770 |
| 114 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.21491067 |
| 115 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.21145120 |
| 116 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.16715036 |
| 117 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.16541068 |
| 118 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15032527 |
| 119 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.14374236 |
| 120 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.11975249 |
| 121 | Lysosome_Homo sapiens_hsa04142 | 0.11839540 |
| 122 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.11403878 |

